Navigation Links
New Generation Xcelodose(R)S Precision Drug Powder Micro-filling System Offers 50% Increased Throughput
Date:11/1/2007

CAMBRIDGE, England, November 1 /PRNewswire-FirstCall/ -- Capsugel will unveil the successor to its unique Xcelodose system for micro-dosing of drug powders into capsules and vials at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting in San Diego (November 11th -15th, 2007).

The new Xcelodose S system will feature a 50% increase in throughput rate for filled capsules. Additional improvements include an integral High Throughput Unit and expanded software functionality.

These enhancements will be available in both the 120 and 600 models, which will replace the existing Xcelodose products. The Xcelodose system, launched in 2002, revolutionized the preparation of drug materials for early stage clinical trials and formulation development. For the first time, pharmaceutical companies could fill pure Active Pharmaceutical Ingredient (API) directly into capsules or other small dose containers, with a level of accuracy and precision previously unattainable.

By automatically dispensing drug substance alone into capsules, pharmaceutical companies can benefit from a reduction in development time by as much as six months. Eliminating the need for formulation for early stage trials enables companies to more quickly reach the crucial "Go/No Go" point for continuing development following Phase I clinical studies. In short, the Xcelodose system has made achieving the goal of "Faster Time to First in Man" a reality.

David Edwards, Director of Pharmaceutical Technology for Capsugel, said the impetus behind the new generation of Xcelodose machines was increased throughput. "Since we originally launched Xcelodose, we have found that batch sizes have increased tenfold; from thousands of capsules per batch, to tens of thousands or more per batch. It became clear that the number one customer requirement was for increased throughput, followed closely by reliability over longer runs."

Keith Hutchison, Capsugel's Vice-President of R&D, re-affirmed the company's commitment to innovation. "With more than 50 Xcelodose systems installed at pharmaceutical, biotech and CRO companies worldwide, capsule micro-filling has become an established technology for early stage clinical trials. Our goal with the Xcelodose S is to substantially advance our strategy of providing innovative solutions to our customers."

The new Xcelodose S system will be featured at Capsugel Booth #691 at the AAPS Annual Meeting.

Note to Editors:

Capsugel, the world's leading provider of dosage form solutions to the pharmaceutical and related healthcare industries, is a division of Pfizer Inc. Offering a diverse array of products and services, Capsugel is at the forefront of drug delivery innovation. Recent product launches include the CFS 1200 Liquid Filling and Sealing Machine and the Xcelodose S Precision Powder Micro-filling System. Both utilize advanced technology that can better enable R&D scientists to accelerate the pace of drug development.


'/>"/>
SOURCE Capsugel
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Indian Doctor granted US patent on organ regeneration
2. New Laser Techniques cure degeneration of the eye
3. Proper Diet Can Counter Macular Degeneration
4. Fast screening for macular degeneration
5. Gene treatment for macular degeneration
6. Laser may stop macular degeneration
7. Macular Degeneration treatment with Laser
8. Age-Related Macular Degeneration - Risk Factors
9. Regeneration of muscle
10. Effective Treatment Option For Macular Degeneration
11. Third generation Small pox vaccine from Cell-culture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... "FCPX editors ... customizable inside of Final Cut Pro X," said Christina Austin - CEO of Pixel ... style. Final Cut Pro X users can now reveal the media of ...
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating ... Millions of individuals in the United States and Canada wear eyeglasses. Once considered to ... correct vision and make a fashion statement. Even celebrities use glasses as a way ...
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Research and Markets has ... Market Analysis 2016 - Forecast to 2022" report to ... report contains up to date financial data derived from varied ... major trends with potential impact on the market during the ... segmentation which comprises of sub markets, regional and country level ...
(Date:6/23/2016)... Ill. and INDIANAPOLIS , ... students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship is ... 2016 scholarship winners, announced today online at www.diabetesscholars.org ... let type 1 diabetes stand in the way of ... has supported the Foundation,s scholarship program since 2012, and ...
(Date:6/23/2016)... Research and Markets has announced the addition ... States, China, Japan, Brazil, United Kingdom, Germany, France, Italy, ... Surgical Procedure Volumes: Global ... surgical procedure volume data in a geographic context. The ... of growth drivers and inhibitors, including world population growth, ...
Breaking Medicine Technology: